New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
August 18, 2021 - The FDA approved Mayne Pharma’s Lexette (halobetasol propionate), for the topical treatment of plaque psoriasis in patients 12 years of age and older.
Download PDF
Return to publications
